Literature DB >> 15063364

New insights into the pathogenesis and therapy of Behçet's disease.

Thurayya Arayssi1, Ayad Hamdan.   

Abstract

Behçet's disease is a chronic multisystem inflammatory disease characterized by the predominance of Th1 cytokines. The human leukocyte antigen-B 51 gene is associated with the disease in several ethnic groups, but it is not certain whether it is the susceptibility gene or if it is in linkage disequilibrium with other genes. Recent studies of polymorphisms of neighboring, as well as distant, genes to human leukocyte antigen-B 51 are helpful in elucidating the pathogenesis of the disease and could have therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063364     DOI: 10.1016/j.coph.2003.10.009

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  9 in total

1.  Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison.

Authors:  Ayad Hamdan; Wissam Mansour; Imad Uthman; Abdel Fattah Masri; Fouad Nasr; Thurayya Arayssi
Journal:  Clin Rheumatol       Date:  2005-11-15       Impact factor: 2.980

Review 2.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 3.  Cytokines in autoimmune uveitis.

Authors:  Reiko Horai; Rachel R Caspi
Journal:  J Interferon Cytokine Res       Date:  2011-07-25       Impact factor: 2.607

4.  Superior vena cava syndrome associated with Behcet's disease and 18 months' follow up: a case report.

Authors:  Ilhan Sezer; M Alkan Melikoglu; H Fatih Cay; Hilal Kocabaş; Bülent Bütün
Journal:  Rheumatol Int       Date:  2008-01-09       Impact factor: 2.631

5.  T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease.

Authors:  Gamze Alayli; Fatma Aydin; Ahmet Yilmaz Coban; Yüksel Süllü; Ferhan Cantürk; Yüksel Bek; Belma Durupinar; Tayyar Cantürk
Journal:  Clin Rheumatol       Date:  2007-01-09       Impact factor: 3.650

6.  Long-term colchicine therapy in a patient with Behçet's disease and acute promyelocytic leukemia.

Authors:  Hakan Ozdogu; Can Boga; Zerrin Yilmaz; Feride Iffet Sahin; Nebil Bal
Journal:  Rheumatol Int       Date:  2006-12-20       Impact factor: 3.580

7.  Cross-cultural adaptation and validation of Behçet's disease quality of life questionnaire.

Authors:  Zahi Touma; Lilian Ghandour; Abla Sibai; Houry Puzantian; Ayad Hamdan; Omar Hamdan; Jeanine Menassa; Imad Uthman; Thurayya Arayssi
Journal:  BMC Med Res Methodol       Date:  2011-04-20       Impact factor: 4.615

8.  New insights in the clinical understanding of Behçet's disease.

Authors:  Sung Bin Cho; Suhyun Cho; Dongsik Bang
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

9.  Evaluation of Serum Homocysteine and Leptin Levels in Patients with Uveitis.

Authors:  Arif Emre Elbay; Ayşen Topalkara; Ahmet Elbay; Haydar Erdoğan; Ayşe Vural; Abdi Bahadır Çetin
Journal:  Turk J Ophthalmol       Date:  2015-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.